Viridian Therapeutics, Inc. VRDN Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Viridian Therapeutics, Inc. (VRDN) reported accretion (amortization) of discounts and premiums, investments of $1.86M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Viridian Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 20.0% year-over-year, from $2.32M to $1.86M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a 62.7% compound annual growth rate (CAGR), from -$965K to $6.76M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to interest income or expense resulting from the amortization of premiums or accretion of discounts on debt securities held as investments. It reflects the gradual adjustment of the carrying value of investment securities toward their face value over time. This metric is essential for reconciling net income to cash flow from operations by removing non-cash accounting impacts.